Daniel Doberer Selected Research

Gilbert Disease

12/2021	Serum metabolomics analysis reveals increased lipid catabolism in mildly hyperbilirubinemic Gilbert's syndrome individuals.
9/2021	Oxidative Stress and Related Biomarkers in Gilbert's Syndrome: A Secondary Analysis of Two Case-Control Studies.
1/2021	Gilbert's Syndrome and the Gut Microbiota - Insights From the Case-Control BILIHEALTH Study.
1/2018	Mild hyperbilirubinaemia as an endogenous mitigator of overweight and obesity: Implications for improved metabolic health.
3/2016	Longer telomeres in chronic, moderate, unconjugated hyperbilirubinaemia: insights from a human study on Gilbert's Syndrome.
10/2013	Anti-genotoxic potential of bilirubin in vivo: damage to DNA in hyperbilirubinemic human and animal models.
9/2013	Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome.
9/2013	Haem catabolism: a novel modulator of inflammation in Gilbert's syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Doberer Research Topics

Disease

8	Gilbert Disease 12/2021 - 09/2013
4	Inflammation (Inflammations) 01/2022 - 09/2013
4	Acidosis 12/2009 - 06/2005
3	Asthma (Bronchial Asthma) 09/2020 - 09/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 09/2013
2	Obesity 01/2018 - 01/2016
2	Alkalosis 04/2014 - 06/2005
2	Neoplasms (Cancer) 10/2013 - 09/2013
2	Ischemia 08/2012 - 06/2011
2	Fibrosis (Cirrhosis) 09/2007 - 06/2005
1	COVID-19 01/2022
1	Dyslipidemias (Dyslipidemia) 12/2021
1	Metabolic Diseases (Metabolic Disease) 12/2021
1	Type 2 Diabetes Mellitus (MODY) 12/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Sleep Wake Disorders 09/2020
1	Hypersensitivity (Allergy) 09/2020
1	Respiratory Tract Diseases (Respiratory Tract Disease) 09/2020
1	Lung Neoplasms (Lung Cancer) 09/2020
1	Overweight 01/2018
1	Hyperbilirubinemia 01/2017
1	Hypernatremia 04/2014
1	Noncommunicable Diseases 09/2013
1	Hyperemia 08/2012
1	Reperfusion Injury 08/2012
1	Body Weight (Weight, Body) 08/2012
1	Heart Arrest (Cardiac Arrest) 02/2009
1	Lactic Acidosis 09/2007
1	Critical Illness (Critically Ill) 09/2007
1	Sepsis (Septicemia) 09/2007
1	Familial Primary Pulmonary Hypertension 01/2007
1	Liver Diseases (Liver Disease) 09/2006
1	Hypoalbuminemia 09/2006
1	Acute Liver Failure (Fulminant Hepatic Failure) 09/2006
1	Wounds and Injuries (Trauma) 10/2005
1	Liver Cirrhosis (Hepatic Cirrhosis) 06/2005
1	Respiratory Alkalosis 06/2005

Drug/Important Bio-Agent (IBA)

7	BilirubinIBA 12/2021 - 09/2013
6	AcidsIBA 04/2014 - 06/2005
3	LipidsIBA 12/2021 - 09/2013
3	Heme (Haem)IBA 01/2021 - 09/2013
2	Biomarkers (Surrogate Marker)IBA 09/2021 - 09/2013
2	AlbuminsIBA 09/2006 - 06/2005
1	sotrovimabIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 09/2021
1	Antimutagenic Agents (Antimutagens)IBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2016
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2016
1	SodiumIBA 04/2014
1	Bile Pigments (Bilin)IBA 10/2013
1	DNA (Deoxyribonucleic Acid)IBA 10/2013
1	AntioxidantsIBA 10/2013
1	Interleukin-6 (Interleukin 6)IBA 09/2013
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 09/2013
1	IronIBA 09/2013
1	Heme Oxygenase-1IBA 08/2012
1	heme arginateIBA 08/2012
1	Phosphocreatine (Neoton)IBA 06/2011
1	BuffersIBA 12/2009
1	Bicarbonates (Hydrogen Carbonate)IBA 12/2009
1	AnionsIBA 09/2007
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2007
1	Lactic Acid (Lactate)FDA LinkGeneric 09/2006
1	Acetaminophen (Paracetamol)FDA LinkGeneric 09/2006
1	ElectrolytesIBA 06/2005

Therapy/Procedure

3	Therapeutics 09/2020 - 09/2015
1	Precision Medicine 09/2020
1	Resuscitation 12/2009
1	Induced Hypothermia 02/2009